33197761|t|NaoXinTong Capsule ameliorates memory deficit in APP/PS1 mice by regulating inflammatory cytokines.
33197761|a|Alzheimer's disease (AD) is the most common neurodegenerative disease in aging population. Neuroinflammation, hyperphosphorylated Tau (p-Tau) and the imbalance between production and clearance of beta-amyloid peptide (Abeta) are the major causes for AD development. NaoXinTong Capsule (NXT), a traditional Chinese medicine, is wildly used for treatment of cardiovascular and cerebrovascular diseases. Hence, we used the double transgenic mice expressing chimeric human amyloid precursor protein and mutant human presenilin 1 (APP/PS1) and HT-22 cells to determine the neuroprotective effects of NXT in AD development and the involved mechanisms. The 3-month-old APP/PS1 mice were randomly divided into 3 groups and received following treatment: Control group, mice were fed normal chow; NXT groups, mice were fed normal chow containing NXT at a normal and a high dose, respectively. While the age-matched C57BL/6J mice fed normal chow were used as the normal control. The NXT treatment was lasted for 5 months. We found that NXT treatment improved spatial memory impairment and cognitive decline in APP/PS1 mice by decreasing p-Tau levels and Abeta accumulation in the brain. Mechanistically, we observed that NXT inhibited neuron atrophy and apoptosis by downregulating inflammatory cytokines, interleukin 1beta (IL-1beta), IL-6 and tumor necrosis factor alpha (TNF-alpha), and inflammation mediators, nuclear factor kappaB (NF-kappaB) and toll-like receptor 4 (TLR4) in the brain. Consistently, NXT blocked l-glutamic acid-induced reactive oxygen species production, inflammation and apoptosis in HT-22 cells partially by inhibiting TLR4/NF-kappaB/IL-1beta signaling pathway. Our study demonstrates that NXT ameliorates AD by reducing p-Tau, Abeta accumulation, inflammation and neuron apoptosis via regulation of TLR4-mediated inflammatory system. It also suggests the potential application of NXT for AD treatment.
33197761	0	18	NaoXinTong Capsule	Chemical	-
33197761	31	45	memory deficit	Disease	MESH:D008569
33197761	53	56	PS1	Gene	19164
33197761	57	61	mice	Species	10090
33197761	76	88	inflammatory	Disease	MESH:D007249
33197761	100	119	Alzheimer's disease	Disease	MESH:D000544
33197761	121	123	AD	Disease	MESH:D000544
33197761	144	169	neurodegenerative disease	Disease	MESH:D019636
33197761	191	208	Neuroinflammation	Disease	MESH:D000090862
33197761	318	323	Abeta	Gene	11820
33197761	350	352	AD	Disease	MESH:D000544
33197761	366	384	NaoXinTong Capsule	Chemical	-
33197761	386	389	NXT	Chemical	-
33197761	406	422	Chinese medicine	Chemical	-
33197761	456	499	cardiovascular and cerebrovascular diseases	Disease	MESH:D002318
33197761	538	542	mice	Species	10090
33197761	563	568	human	Species	9606
33197761	569	594	amyloid precursor protein	Gene	351
33197761	606	611	human	Species	9606
33197761	612	624	presenilin 1	Gene	5663
33197761	630	633	PS1	Gene	19164
33197761	639	644	HT-22	CellLine	CVCL:0321
33197761	695	698	NXT	Chemical	-
33197761	702	704	AD	Disease	MESH:D000544
33197761	766	769	PS1	Gene	19164
33197761	770	774	mice	Species	10090
33197761	860	864	mice	Species	10090
33197761	887	890	NXT	Chemical	-
33197761	899	903	mice	Species	10090
33197761	936	939	NXT	Chemical	-
33197761	1005	1013	C57BL/6J	CellLine	CVCL:C0MW
33197761	1014	1018	mice	Species	10090
33197761	1072	1075	NXT	Chemical	-
33197761	1125	1128	NXT	Chemical	-
33197761	1156	1173	memory impairment	Disease	MESH:D008569
33197761	1178	1195	cognitive decline	Disease	MESH:D003072
33197761	1203	1206	PS1	Gene	19164
33197761	1207	1211	mice	Species	10090
33197761	1243	1248	Abeta	Gene	11820
33197761	1310	1313	NXT	Chemical	-
33197761	1331	1338	atrophy	Disease	MESH:D001284
33197761	1371	1383	inflammatory	Disease	MESH:D007249
33197761	1395	1412	interleukin 1beta	Gene	16176
33197761	1414	1422	IL-1beta	Gene	16176
33197761	1425	1429	IL-6	Gene	16193
33197761	1434	1461	tumor necrosis factor alpha	Gene	21926
33197761	1463	1472	TNF-alpha	Gene	21926
33197761	1479	1491	inflammation	Disease	MESH:D007249
33197761	1526	1535	NF-kappaB	Gene	18033
33197761	1541	1561	toll-like receptor 4	Gene	21898
33197761	1563	1567	TLR4	Gene	21898
33197761	1597	1600	NXT	Chemical	-
33197761	1609	1624	l-glutamic acid	Chemical	MESH:D018698
33197761	1633	1656	reactive oxygen species	Chemical	MESH:D017382
33197761	1669	1681	inflammation	Disease	MESH:D007249
33197761	1699	1704	HT-22	CellLine	CVCL:0321
33197761	1735	1739	TLR4	Gene	21898
33197761	1740	1749	NF-kappaB	Gene	18033
33197761	1750	1758	IL-1beta	Gene	16176
33197761	1806	1809	NXT	Chemical	-
33197761	1822	1824	AD	Disease	MESH:D000544
33197761	1844	1849	Abeta	Gene	11820
33197761	1864	1876	inflammation	Disease	MESH:D007249
33197761	1916	1920	TLR4	Gene	21898
33197761	1930	1942	inflammatory	Disease	MESH:D007249
33197761	1997	2000	NXT	Chemical	-
33197761	2005	2007	AD	Disease	MESH:D000544
33197761	Association	MESH:D008569	11820
33197761	Positive_Correlation	MESH:D018698	MESH:D007249
33197761	Association	MESH:D007249	21926
33197761	Association	MESH:D007249	16193
33197761	Association	MESH:D000544	11820
33197761	Positive_Correlation	MESH:D017382	MESH:D018698
33197761	Association	MESH:D007249	21898
33197761	Association	MESH:D007249	16176
33197761	Association	351	5663
33197761	Association	MESH:D000544	21898
33197761	Association	MESH:D007249	18033

